 |
|
Hospital Costs and Mortality Attributed to Nosocomial Bacteremias
Robert F. Spengler, ScD;
William B. Greenough III, MD
JAMA. 1978;240(22):2455-2458.
Abstract
Hospital patients with nosocomial bacteremia and matched hospital control patients without this infection were used to determine the excess hospital costs and mortality attributed to nosocomial bacteremias. Mortality was 14 times greater in patients with nosocomial bacteremia than in matched members of the control group with the same primary diagnoses. An itemized cost analysis, based on 81 case-control pairs, showed an average excess of approximately $3,600 in direct hospital costs for patients who had nosocomial bacteremias. It is estimated that only 24% of the total excess costs to these hospital patients are preventable. Patients with nosocomial bacteremia had an average hospitalization period that was 14 days longer than the average hospital stay for members of the control group.
(JAMA 240:2455-2458, 1978)
Author Affiliations
From the Department of Epidemiology and Health, McGill University, Montreal (Dr Spengler), and Department of Medicine, The Johns Hopkins Hospital, Baltimore (Dr Greenough). Dr Spengler is now with the Ontario Cancer Foundation, Toronto. Dr Greenough is now with Biomedical Science Program, Cholera Research Laboratory, Dacca, Bangladesh.
Footnotes
Reprint requests to Division of Epidemiology and Statistics, Ontario Cancer Foundation, 7 Overlea Blvd, Toronto, Ontario, Canada M4H 1A8 (Dr Spengler).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Kim et al.
J Antimicrob Chemother 2004;54:489-497.
ABSTRACT
| FULL TEXT
Effects of Rapid Detection of Bloodstream Infections on Length of Hospitalization and Hospital Charges
Beekmann et al.
J. Clin. Microbiol. 2003;41:3119-3125.
ABSTRACT
| FULL TEXT
Evaluation of Outcome of Intravenous Catheter-related Infections in Critically Ill Patients
RELLO et al.
Am. J. Respir. Crit. Care Med. 2000;162:1027-1030.
ABSTRACT
| FULL TEXT
The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit
DIGIOVINE et al.
Am. J. Respir. Crit. Care Med. 1999;160:976-981.
ABSTRACT
| FULL TEXT
The Effectiveness of Right Heart Catheterization in the Initial Care of Critically III Patients
Connors et al.
JAMA 1996;276:889-897.
ABSTRACT
Costs of Potential Complications of Care for Major Surgery Patients
Kalish et al.
American Journal of Medical Quality 1995;10:48-54.
ABSTRACT
Nosocomial Bloodstream Infection in Critically III Patients: Excess Length of Stay, Extra Costs, and Attributable Mortality
Pittet et al.
JAMA 1994;271:1598-1601.
ABSTRACT
Coagulase-Negative Staphylococcal Bacteremia: Mortality and Hospital Stay
Martin et al.
ANN INTERN MED 1989;110:9-16.
ABSTRACT
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey et al.
Arch Intern Med 1988;148:2642-2645.
ABSTRACT
|
